Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gary Sachs

Psychiatry Boston, MA Medical Doctor

NPI 1386605277 CMS profile 335176

15 Parkman St, Wac 8, Boston, MA 02114

Open in the dashboard

General payments

$80,557

72 records reported · program years 2019–2025

Research payments

$1,179

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gary Sachs of Boston, MA is reported in the CMS Open Payments database as having received $80,557 across 72 general payments and $1,179 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24,109 29
2025 Research $1,179 10
2024 General $6,966 8
2023 General $35,168 23
2021 General $3,952 4
2020 General $4,400 1
2019 General $5,963 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gary Sachs
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Gary Sachs were reported at $24,109. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Gary Sachs Psychiatry median Middle half National median
2019 $5,963 $184 $59–$605 $163
2020 $4,400 $119 $36–$372 $114
2021 $3,952 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $35,168 $170 $56–$651 $160
2024 $6,966 $179 $57–$673 $164
2025 $24,109 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $21,734 28 payments
  2. ITI, Inc. $18,620 8 payments
  3. Merck Sharp & Dohme Corporation $15,346 19 payments
  4. LivaNova USA, Inc. $7,514 5 payments
  5. H. Lundbeck A S $6,267 7 payments
  6. SK Life Science, Inc. $4,400 1 payment
  7. Genentech, Inc. $4,230 2 payments
  8. E.R. Squibb & Sons, L.L.C. $2,375 1 payment
  9. Sunovion Pharmaceuticals Inc. $70 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $58,559 13 payments
  2. Travel and Lodging $9,892 26 payments
  3. Honoraria $9,500 4 payments
  4. Food and Beverage $1,783 28 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $824 1 payment
Products named General payments · program years 2019–2025
  1. CAPLYTA $18,620 8 payments
  2. VNS Therapy Symmetry Model 8103 Generator $7,514 5 payments
  3. ABILIFY MAINTENA $5,567 6 payments
  4. BOTOX $5,400 1 payment
  5. Cenobamate $4,400 1 payment
  6. REXULTI $700 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $1,179 10 payments

Records

82 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record